Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
MTEMQ (MTEMQ)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/04/2025: MTEMQ (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 860.73% | Avg. Invested days 54 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 06/04/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range - | Updated Date 06/10/2025 |
52 Weeks Range - | Updated Date 06/10/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
MTEMQ
Company Overview
History and Background
MTEMQ represents the stock of Momentive Performance Materials Inc., which filed for Chapter 11 bankruptcy. It was formerly a global leader in silicones and advanced materials, serving various industries. The company was founded in 2006 as a spin-off from General Electric's GE Advanced Materials division.
Core Business Areas
- Silicones: MTEMQ's silicones business produced and sold a wide range of silicone-based products, including sealants, adhesives, fluids, and elastomers, used in construction, automotive, electronics, and consumer goods.
- Quartz: The quartz business specialized in high-purity quartz materials for semiconductor, lighting, and other high-tech applications.
Leadership and Structure
Prior to bankruptcy, Momentive's leadership included a CEO, CFO, and various business unit heads. The organizational structure was hierarchical, with functional departments and business segments.
Top Products and Market Share
Key Offerings
- Silicone Sealants and Adhesives: Used in construction, automotive, and industrial applications. Competitors include Dow, Wacker Chemie, and Shin-Etsu Chemical. Market share data is unavailable post bankruptcy.
- Silicone Fluids: Used in personal care products, textiles, and other applications. Competitors include Dow, Wacker Chemie, and Shin-Etsu Chemical. Market share data is unavailable post bankruptcy.
- Quartz Crucibles: Used in the production of solar panels and semiconductors. Competitors include Heraeus and Tosoh. Market share data is unavailable post bankruptcy.
Market Dynamics
Industry Overview
The silicones and advanced materials industry is characterized by global competition, technological innovation, and cyclical demand. The quartz industry is driven by the semiconductor and solar panel markets.
Positioning
Before bankruptcy, Momentive was a major player in the silicones and quartz markets, known for its technology and product portfolio. However, high debt levels negatively impacted its competitiveness. Its position is significantly weakened after bankruptcy filing.
Total Addressable Market (TAM)
The total market value for silicones and advanced materials is estimated to be hundreds of billions of dollars annually. Momentive's pre-bankruptcy position allowed them to capture a significant portion. Post bankruptcy, their share is substantially reduced.
Upturn SWOT Analysis
Strengths
- Established Brand (pre-bankruptcy)
- Broad Product Portfolio (pre-bankruptcy)
- Technological Expertise (pre-bankruptcy)
Weaknesses
- High Debt Levels (leading to bankruptcy)
- Bankruptcy Filing
- Damaged Reputation
- Reduced Access to Capital
Opportunities
- Restructuring and Re-emergence
- Focus on High-Margin Products
- New Product Development
- Strategic Partnerships
Threats
- Intense Competition
- Economic Downturn
- Fluctuations in Raw Material Prices
- Further Legal Challenges
Competitors and Market Share
Key Competitors
- DOW
- WCH
- SHIEF.SI
Competitive Landscape
Prior to bankruptcy, Momentive was a significant competitor, but its financial difficulties weakened its position. Now, it does not exist.
Major Acquisitions
Sea Lion Technology, Inc.
- Year: 2014
- Acquisition Price (USD millions): 0
- Strategic Rationale: Acquired Sea Lion Technology to add silicone rubber compounding capacity in Asia
Growth Trajectory and Initiatives
Historical Growth: Pre-bankruptcy growth was moderate but hampered by debt.
Future Projections: Future growth is uncertain and dependent on the success of the restructuring and re-emergence from bankruptcy.
Recent Initiatives: Focus on restructuring and debt reduction.
Summary
Momentive Performance Materials (MTEMQ) filed for bankruptcy due to substantial debt. Prior to bankruptcy, it was a strong player in silicones and quartz. The company's bankruptcy significantly weakened its market position. Future success depends on effective restructuring. Investors should exercise extreme caution when considering any investment, especially with MTEMQ, given its bankruptcy status and challenges with reorganization. The bankruptcy has significant impact on shareholders.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings (pre-bankruptcy)
- Company Press Releases (pre-bankruptcy)
- Industry Reports
- News Articles
Disclaimers:
The information provided is based on historical data and publicly available sources prior to the bankruptcy. The company's current financial situation and future prospects are highly uncertain. This is not investment advice. MTEMQ no longer exists
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MTEMQ
Exchange NASDAQ | Headquaters Austin, TX, United States | ||
IPO Launch date - | President, CEO & CFO Craig Jalbert | ||
Sector Healthcare | Industry Biotechnology | Full time employees 62 | Website https://www.mtem.com |
Full time employees 62 | Website https://www.mtem.com | ||
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.